← Back to Search

High-intensity interval training (HIIT)-4 for Type 2 Diabetes

N/A
Recruiting
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, in fasted state
Awards & highlights

Study Summary

This trial will test if HIIT can help type 2 diabetics by reducing cardiovascular risks.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, in fasted state
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, in fasted state for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ambulatory systolic and diastolic blood pressure
Secondary outcome measures
Change in 24h glycemia
Change in arterial stiffness
Change in monocyte-derived macrophages polarization
+16 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Rest, HIIT-4, HIIT-10Experimental Treatment3 Interventions
Both arms start with the rest condition and the order of the two other conditions (HIIT-4 and HIIT-10) is determined at random. This arm's sequence of intervention is : 1-Rest; 2- HIIT-4 and 3- HIIT-10.
Group II: Rest, HIIT-10, HIIT-4Experimental Treatment3 Interventions
Both arms start with the rest condition and the order of the two other conditions (HIIT-4 and HIIT-10) is determined at random. This arm's sequence of intervention is : 1- Rest; 2- HIIT-10 and 3- HIIT-4.

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
298 Previous Clinical Trials
69,926 Total Patients Enrolled
~4 spots leftby Jun 2025